http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018193232-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77daaba4ed8a52f189334aef53bbffc8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-54
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-042
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-02
filingDate 2018-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_992a5a80cab825cada01f9746c7b7912
publicationDate 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018193232-A1
titleOfInvention Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use
abstract The object of the present invention is an injectable sterile aqueous formulation, ready-to-use, resorbable, used for aesthetic purposes as a particulate, cohesive, viscoelastic gel comprising i) crosslinked hyaluronic acid, or one of its salts, at a concentration of between 1% and 4% (mass/volume); the crosslinking carried out providing the possibility of obtaining a gel based on crosslinked hyaluronic acid with a so-called cohesive structure, and ii) hydroxyapatite, at a concentration of between 5% and 60% (mass/volume), said hydroxyapatite being in the form of particles with an average size of less than or equal to 200 μm; said injectable sterile aqueous formulation having viscoelastic properties such that tan δ at the frequency of 1 Hz is less than or equal to 0.60.
priorityDate 2012-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010136694-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922025-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16219577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18679986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22065397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1738118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12862484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428

Total number of triples: 74.